Zobrazeno 1 - 4
of 4
pro vyhledávání: '"XTuit Pharmaceuticals, Inc."'
Autor:
Wiznerowicz M; Laboratory for Gene Therapy at the Greater Poland Cancer Center, Poznan, Poland; Deparment of Cancer Immunology, Chair of Medical Biotechnology at the Poznan University of Medical Sciences, Poznan, Poland., Shah PK; Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andersen JN; Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center, Houston, TX, USA; XTuit Pharmaceuticals, Inc., Boston, MA, USA.
Publikováno v:
Contemporary oncology (Poznan, Poland) [Contemp Oncol (Pozn)] 2015; Vol. 19 (1A), pp. 1-2. Date of Electronic Publication: 2015 Jan 20.
Autor:
Shipitsin M; Metamark Genetics Inc, Cambridge, MA, USA., Small C; Metamark Genetics Inc, Cambridge, MA, USA., Giladi E; Metamark Genetics Inc, Cambridge, MA, USA ; Current address: Atreca, San Carlos, CA, USA., Siddiqui S; Metamark Genetics Inc, Cambridge, MA, USA ; Current address: Moderna, Cambridge, MA, USA., Choudhury S; Metamark Genetics Inc, Cambridge, MA, USA., Hussain S; Metamark Genetics Inc, Cambridge, MA, USA., Huang YE; Metamark Genetics Inc, Cambridge, MA, USA., Chang H; Metamark Genetics Inc, Cambridge, MA, USA., Rimm DL; Department of Pathology, Yale University Medical School, New Haven, CT, USA., Berman DM; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada., Nifong TP; Metamark Genetics Inc, Cambridge, MA, USA., Blume-Jensen P; Metamark Genetics Inc, Cambridge, MA, USA ; Current address: XTuit Pharmaceuticals, Inc, Cambridge, MA, USA.
Publikováno v:
Proteome science [Proteome Sci] 2014 Jul 12; Vol. 12, pp. 40. Date of Electronic Publication: 2014 Jul 12 (Print Publication: 2014).